Discovery of micromolar PDE IV inhibitors that exhibit much reduced affinity for the [3H]rolipram binding site: 3-norbornyloxy-4-methoxyphenylmethylene oxindoles

https://doi.org/10.1016/0960-894X(95)00333-OGet rights and content

Abstract

The synthesis and the in vitro properties of a novel series of potent and selective phosphodiesterase type IV (PDE IV) inhibitors is described. Despite bearing structural similarity to rolipram, several of these compounds have much reduced affinity for the [3H]rolipram binding site.

The synthesis and the in vitro properties of a novel series of potent and selective phosphodiesterase type IV (PDE IV) inhibitors is described. Despite bearing structural similarity to rolipram, several of these compounds have much reduced affinity for the [3H]rolipram binding site.

  1. Download : Download full-size image

References (26)

  • J.A. Beavo et al.

    Trends Pharmacol. Sci.

    (1990)
  • C.D. Nicholson et al.

    Trends Pharmacol. Sci.

    (1991)
  • A.J. Duplantier et al.

    Annu. Rep. Med. Chem.

    (1994)
  • S.B. Christensen et al.

    Annu. Rep. Med. Chem.

    (1994)
  • M.S. Barnette

    Challenges for Drug Discovery

    New Drugs for Asthma-III

    (July, 1994)
  • N.A. Saccomano et al.

    J. Med. Chem.

    (1991)
  • P.J. Barnes et al.

    Eur. Respir. J.

    (1994)
  • J.A. Lowe et al.

    Drugs Fut.

    (1992)
  • M.A. Giembycz et al.

    Clin. Exp. Allergy

    (1992)
  • T.J. Torphy et al.

    Drug News and Perspective

    (1993)
  • C.D. Nicholson et al.

    Pulm. Pharmacol.

    (1994)
  • A. Matsuura et al.

    Biol. Pharm. Bull.

    (1994)
  • Cited by (0)

    View full text